Potent Sulfadoxine-Pyrimethamine 500-25mg Tabs | Your Reliable Antimalarial Arsenal
ProcurenetShort description
Sulfadoxine-Pyrimethamine 500-25mg Tablets: Reliable Malaria & Toxoplasmosis Suppressant
- Enduring Effectiveness: Offers sustainable protection against both malaria and toxoplasmosis
- Mechanism of Action: Disrupts crucial folate synthesis in parasites and inhibit nucleic acids synthesis by selectively targeting dihydropteroate synthase
- Shelf Life: Standard shelf life of 36 months supports long-term storage and extensive coverage
- Therapeutic Versatility: Exhibits broad-range antiparasitic properties, making it an ideal treatment for toxoplasmosis in HIV positive patients
-
Procurenet Team Tshim Sha Tsui
Hong Kong
3 years
Description
Sulfadoxine-Pyrimethamine 500-25mg: Powerful Malaria Prevention & Robust Treatment
Discover the unsurpassed efficacy of Sulfadoxine-Pyrimethamine 500-25mg tabs, a cutting-edge solution crafted to combat the perils of malaria, particularly falciparum malaria. Specifically designed to also safeguard pregnant women from the threat of malaria, this ground-breaking blend comprises Sulfadoxine 500mg and Pyrimethamine 25mg, a dynamic duo that diligently halts the generation of parasite nucleic acids.
Key Features:
- Sustained protection with proven long-term efficacy
- Competitive obstruction of the enzyme dihydropteroate synthase
- Effective inhibition of parasite nucleic acids production
- Standard 36-month shelf life ensures longevity and cost-effectiveness
- Capable of countering toxoplasmosis in HIV patients
Usage Guidelines:
Maximize the benefits of Sulfadoxine-Pyrimethamine 500-25mg tabs by consuming them orally after meals, while ensuring adequate intake of fluids. Sunlight exposure should be reduced during usage. It's important to keep the tablets enclosed in the original packaging and away from light.
Recommended Storage:
Maintain a storage temperature below 30°C and ensure the product is beyond reach and sight of children.
Note: Sulfadoxine-Pyrimethamine 500-25mg tabs qualify under the Emergency Supply List and may be made available with an oral suspension alternative in specific markets.
